Clinical trial
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
NCT00308308 · Mannkind Corporation, Industry · Completed
Key facts
| NCT number | NCT00308308 |
|---|---|
| Title | Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes |
| Official title | A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 1 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Basal and Prandial Insulin Over a 52-Week… |
| Lead sponsor | Mannkind Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Type I |
| Intervention type | Drug |
| Interventions | Technosphere Insulin, Active comparator |
| Enrollment | 589 |
| Start date | Feb 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Mar 29, 2006 |
| Last update posted | Oct 16, 2014 |
| Countries | Argentina, Brazil, Canada, Chile, Mexico, Poland, Russia, Spain, United Kingdom, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: